LL-37 (LL-37 — Human Cathelicidin Antimicrobial Peptide): complete research guide covering mechanism of action, amino acid sequence, molecular weight, dosage protocols, and independent analysis.
Mechanism of Action
LL-37 (LL-37 — Human Cathelicidin Antimicrobial Peptide) acts via innate immune defense & immunomodulatory signaling. This compound belongs to the Immune peptide category and is available for research purposes from Purgo Labs.
Amino Acid Sequence & Molecular Data
Complete sequence data, molecular weight, and structural analysis for LL-37 are covered in this research guide.
Research Protocols & Dosage
Evidence-based research protocols, administration routes, and dosage considerations for LL-37 are detailed below.
Research Evidence
Independent analysis of preclinical and clinical research data for LL-37, including key studies and outcome measures.
Sourcing & Quality
LL-37 is available from Purgo Labs with third-party COA verification and research-grade purity standards. View LL-37 at Purgo Labs.